Key result
Review details pathophysiological mechanisms of ischemic heart disease and compensatory coronary vasodilatation.
Why the study?
Ischemic heart disease results from an imbalance between coronary blood flow and myocardial requirements due to changes in coronary circulation, but detailed mechanisms of myocardial impairment need clarification.
Standardizes IHD terminology for nuclear scans; leaves open validation against modern perfusion metrics.
Ischemic Heart Disease is defined as 'myocardial impairment due to an imbalance between coronary blood flow and myocardial requirements caused by changes in the coronary circulation 1 .Coronary artery disease is thought to arise from normal repair processes in response to chronic injuries to the arterial endothelium.As myocardial oxygen demand increases or coronary blood flow decreases, auto-regulatory mechanisms become active to try to maintain myocardial perfusion at a normal level.In patients with atherosclerotic heart disease, compensatory mechanisms to maintain myocardial perfusion stenosis are already active, so first abnormality to be apparent during ischemia is therefore reduced perfusion to the affected territory 2 .During myocardial ischemia ATP is highly utilized resulting in an increase in its metabolites.This subsequently acts as a vasodilator in an attempt to compensate for the reduced perfusion.Various catabolites such as lactate and hydrogen ions accumulate, and these can also cause coronary vasodilatation.
No takes yet. Share an insight, caveat, or question.
Omar et al. (2014) conducted a review in Ischemic Heart Disease. The provided abstract outlines the pathophysiological mechanisms of ischemic heart disease and compensatory coronary vasodilatation without reporting any primary study findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: